Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
|
|
Odonate Therapeutics, Inc. (ODT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2021 |
4
| Boxer Capital, LLC (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Sold 200,000 shares
@ $1.5483, valued at
$309.7k
Sold 200,000 shares
@ $1.5684, valued at
$313.7k
|
|
| 11/19/2021 |
4
| Davis Aaron I. (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Sold 170,000 shares
@ $2.2334, valued at
$379.7k
Sold 600,000 shares
@ $2.1654, valued at
$1.3M
Sold 250,000 shares
@ $1.949, valued at
$487.3k
Sold 30,000 shares
@ $1.9165, valued at
$57.5k
Sold 150,000 shares
@ $1.8419, valued at
$276.3k
|
|
| 11/19/2021 |
4
| Boxer Capital, LLC (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Sold 600,000 shares
@ $2.1654, valued at
$1.3M
Sold 250,000 shares
@ $1.949, valued at
$487.3k
Sold 150,000 shares
@ $1.8419, valued at
$276.3k
|
|
| 11/19/2021 |
4
| TANG KEVIN C (CEO) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Sold 468,849 shares
@ $2.6583, valued at
$1.2M
Sold 31,151 shares
@ $1.9941, valued at
$62.1k
Sold 500,000 shares
@ $2.0161, valued at
$1M
Sold 287,577 shares
@ $2.1985, valued at
$632.2k
Sold 212,423 shares
@ $1.9708, valued at
$418.6k
Sold 500,000 shares
@ $1.8812, valued at
$940.6k
Sold 381,842 shares
@ $1.8925, valued at
$722.6k
Sold 365,289 shares
@ $1.9161, valued at
$699.9k
|
|
| 11/18/2021 |
3
| EcoR1 Capital, LLC (10% Owner) has filed a Form 3 on Odonate Therapeutics, Inc. |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 35 shares
@ $16.99, valued at
$594.7
Granted 35 options to buy
@ $19.99, valued at
$699.7 |
|
| 01/20/2021 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 94 shares
@ $16.99, valued at
$1.6k
Granted 94 options to buy
@ $19.99, valued at
$1.9k
|
|
| 01/05/2021 |
4
| Hearne Michael S (CFO) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 350 shares
@ $16.32, valued at
$5.7k
Granted 350 options to buy
@ $19.2, valued at
$6.7k
|
|
| 01/05/2021 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 169 shares
@ $16.32, valued at
$2.8k
Granted 169 options to buy
@ $19.2, valued at
$3.2k
|
|
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| Boxer Capital, LLC (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Bought 75,000 shares
@ $16.9, valued at
$1.3M
Bought 225,000 shares
@ $17.1091, valued at
$3.8M
Bought 100,000 shares
@ $17.4638, valued at
$1.7M
|
|
| 12/30/2020 |
4
| Davis Aaron I. (10% Owner) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Bought 75,000 shares
@ $16.9, valued at
$1.3M
Bought 225,000 shares
@ $17.1091, valued at
$3.8M
Bought 100,000 shares
@ $17.4638, valued at
$1.7M
|
|
| 12/23/2020 |
4
| TANG KEVIN C (CEO) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Bought 62,144 shares
@ $14.5753, valued at
$905.8k
Bought 37,856 shares
@ $14.5754, valued at
$551.8k
Bought 36,646 shares
@ $15.1673, valued at
$555.8k
Bought 63,354 shares
@ $15.4282, valued at
$977.4k
Bought 75,784 shares
@ $15.708, valued at
$1.2M
|
|
| 12/17/2020 |
4
| Hearne Michael S (CFO) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 43 shares
@ $12.91, valued at
$555.1
Granted 43 options to buy
@ $15.19, valued at
$653.2 |
|
| 12/17/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 121 shares
@ $12.91, valued at
$1.6k
Granted 121 options to buy
@ $15.19, valued at
$1.8k
|
|
| 12/10/2020 |
4
| Hearne Michael S (CFO) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 22,639 options to buy
@ $16.52, valued at
$374k
|
|
| 12/10/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 60,373 options to buy
@ $16.52, valued at
$997.4k
|
|
| 12/10/2020 |
4
| Johnson Laura L. (Director) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $16.52, valued at
$247.8k
|
|
| 12/10/2020 |
4
| Rosen Robert (Director) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $16.52, valued at
$247.8k
|
|
| 12/10/2020 |
4
| Johnson Craig A (Director) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $16.52, valued at
$247.8k
|
|
| 12/02/2020 |
4
| Hearne Michael S (CFO) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 45 shares
@ $12.77, valued at
$574.7
Granted 45 options to buy
@ $15.02, valued at
$675.9 |
|
| 12/02/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 122 shares
@ $12.77, valued at
$1.6k
Granted 122 options to buy
@ $15.02, valued at
$1.8k
|
|
| 12/02/2020 |
4
| Lemkey John G (COO) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 12 shares
@ $12.77, valued at
$153.2
Granted 12 options to buy
@ $15.02, valued at
$180.2 |
|
| 11/17/2020 |
4
| Hearne Michael S (CFO) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 46 shares
@ $12.2, valued at
$561.2
Granted 46 options to buy
@ $14.35, valued at
$660.1 |
|
| 11/17/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 128 shares
@ $12.2, valued at
$1.6k
Granted 128 options to buy
@ $14.35, valued at
$1.8k
|
|
|
|
|